caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1528355120

Li LiM.D.

Internal MedicineClovis, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
PRESCRIBING · PART D · 2024
Total Rx claims
199
Beneficiaries
—
Total drug cost
$1.6M
Distinct drugs
10
Brand share
66.3%
Top prescribed drugs
Osimertinib Mesylate33 claims
Letrozole28 claims
Ribociclib Succinate25 claims
Gabapentin24 claims
Enzalutamide23 claims
QUALITY · MIPS · 2024
Final MIPS score
61.0
Quality
59.4
Cost
71.5
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
-1.68%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
39
Unique beneficiaries
—
Total services
58
Distinct HCPCS
2
Medicare payment
$5K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 10,499 Internal Medicine providers in CA — bottom quintile (cohort median 531).